
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ArcheMedX has announced that it will launch of Ready. Ready is a new digital platform to reduce the risks and costs associated with underperforming clinical trials.
To learn more about the launch, click






